Evidence map›Paper›PMID 25259805›Full record

ArticlePloS one2014

Molecular design and synthesis of novel salicyl glycoconjugates as elicitors against plant diseases.

Zining Cui, Jun Ito, Hirofumi Dohi, Yoshimiki Amemiya, Yoshihiro Nishida

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The Emerging Role ofPlants (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Crystal structure of (Acta crystallographica. Section E, Crystallographic communications · 2018
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Zining CuiGuangdong Province Key Laboratory of Microbial Signals and Disease Control, Department of Plant Pathology, College of Natural Resource and Environment, South China Agricultural University, Guangzhou, China; Department of Nanobiology, Graduate School of Advanced Integration Science, Chiba University, Chiba, Japan; State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, China.
Jun ItoDepartment of Environment Science for Bioproduction, Graduate School of Horticulture, Chiba University, Chiba, Japan.
Hirofumi DohiDepartment of Nanobiology, Graduate School of Advanced Integration Science, Chiba University, Chiba, Japan.
Yoshimiki AmemiyaDepartment of Environment Science for Bioproduction, Graduate School of Horticulture, Chiba University, Chiba, Japan.
Yoshihiro NishidaDepartment of Nanobiology, Graduate School of Advanced Integration Science, Chiba University, Chiba, Japan.
Chiba University · JPChinese Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new series of salicyl glycoconjugates containing hydrazide and hydrazone moieties were designed and synthesized. The bioassay indicated that the novel compounds had no in vitro fungicidal activity but showed significant in vivo antifungal activity against the tested fungal pathogens. Some compounds even had superior activity than the commercial fungicides in greenhouse trial. The results of RT-PCR analysis showed that the designed salicyl glycoconjugates could induce the expression of LOX1 and Cs-AOS2, which are the specific marker genes of jasmonate signaling pathway, to trigger the plant defense resistance.

Indexed as

Antifungal AgentsFungicides, IndustrialGlycoconjugatesHydrazinesMolecular StructurePlant DiseasesPlantsAntifungal AgentsFungicides, IndustrialGlycoconjugatesHydrazinessalicyl hydrazide

Identifiers

PMID25259805
PMCPMC4178153
OpenAlexW2076430978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.